MedWatch

Zealand's Dutch leading investor looks forward to two hectic years: "There are multiple triggers"

Head of Investments for the Dutch family foundation Van Herk, Dharminder Chahal, is looking forward to getting certainty over a number of central points in Zealand Pharma's business plan over the next two years, where the company reaches several milestones.

Dharminder Chahal is head of investments at the Dutch family foundation Van Herk's investment arm, and is behind the foundations investment in Zealand Pharma. Photo: Exponential / PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles